169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Method for detecting cardiac failure patient
#2702BIOMARKERS FOR ANDERSON-FABRY DISEASE
#2703BARD1 isoforms in lung and colorectal cancer and use thereof
#2704Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#2705Method for treating rheumatoid arthritis
#2706Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in Diabetes
#2707Medicament and apparatus for treating chronic kidney disease
#2708Method for inhibiting or reducing transplant rejection by adminstration of interleukin-34
#2709Lymphangiogenesis inhibitors for cancer and for graft survival
#2710Methods for producing hormone secreting cells in a subject
#2711Devices and assays for diagnosis of sinusitis
#2712Blood biomarker for early blood brain barrier disruption in ischemic stroke
#2713Urine Biomarkers for Prediction of Recovery After Acute Kidney Injury: Proteomics
#2714Metabolite panel for improved screening and diagnostic testing of cystic fibrosis
#2715Marker sequences for diagnosing and stratifying systemic sclerosis patients
#2716Surrogates of post-translationally modified proteins and uses thereof
#2717BIOMARKERS OF OXIDATIVE STRESS
#2718Methods for diagnosing and treating eosinophilic esophagitis
#2719METHODS OF USING CELLS ASSOCIATED WITH AUTOIMMUNE DISEASE
#2720Electrochemical methods and devices for amending urine samples for immunosensor detection
#2721Cartridge for diagnostic testing
#2722R2R1/2 in diagnosis and therapy
#2723DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF AMINOACIDOPATHIES
#2724Antibody molecules to TIM-3 and uses thereof
#2725HCBI, MSBI, MSSI AND CMI SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER AND DISEASES OF THE CNS AND AS A TARGET FOR THE TREATMENT AND PREVENTION OF THESE DISEASES
#2726Serine derivatives as ghrelin receptor agonists
#2727Kit and method for detecting porous dental hydroxyapatite
#2728Method for evaluating condition of skin dryness
#2729Antibodies and methods for the detection of cell death
#2730Antibody molecules to TIM-3 and uses thereof
#2731Peptide for Protection of Allergic Respiratory Disorders
#2732Factor involved in latent infection with herpes virus, and use thereof
#2733Diagnostic and therapeutic uses of gelsolin in renal failure
#2734Biomarker-based methods for aiding the diagnosis of stroke
#2735Methods and compositions for diagnosis of ectopic pregnancy
#2736METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#2737Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
#2738METHODS FOR ASSESSING VAGINAL ATROPHY
#2739Fibrosis biomarker assay
#2740Compositions and methods for treating eye infections and disease
#2741Thyroglobulin quantitation by mass spectroscopy
#2742Therapeutic regimen for hypertension
#2743MEASUREMENT OF BODY FLUID VOLUMES
#2744Identification of pneumocystis antigens and uses thereof
#27453-(4-((4-morpholinomethyl-benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus
#2746Preventive or therapeutic agent for kidney disease
#2747P-SELECTIN ASSOCIATED WITH EOSINOPHILS AS A MARKER FOR ASTHMA AND CORRELATING WITH B-1 INTEGRIN ACTIVATION
#2748Biomarkers and Methods for Measuring and Monitoring Inflammatory Disease Activity
#2749Mammalian Dickkopf 3 (DKK3) as Urinary Marker for Chronic Kidney Diseases
#2750In vitro process for the quantification of carboxymethyl and carboxyethyl level of albumin in a sample
#2751Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume
#2752Exosome-mediated diagnosis of hepatitis virus infections and diseases
#2753METHODS OF USING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE TL1A GENE TO PREDICT OR DIAGNOSE INFLAMMATORY BOWEL DISEASE
#2754Method for the diagnosis of or risk for a disease mediated via the alternative pathway of the complement system
#2755A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION
#2756Synergistic combination of biomarkers for detecting and assessing hepatic fibrosis
#2757Biomarkers for assessing HIV
#2758COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE
#2759Metabolomic prediction of congenital heart defect during pregnancy, newborn and pediatric stages
#2760Methods and kits for detecting brain injury
#2761Methods of treatment of primary sclerosing cholangitis
#2762Diagnosis and treatment of Kawasaki disease
#2763Early prediction markers of diabetic nephropathy
#2764Flattop (FLTP) is a novel biomarker for beta cell maturation
#2765Anti-complement factor C1q Fab fragments and uses thereof
#2766Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system
#2767METHOD FOR TEST ON DIABETIC NEPHROPATHY
#2768TEST METHOD ON RENAL DISEASES
#2769Methods for treating or predicting risk of a ventricular tachyarrhythmia event
#2770ANTI-IL4-IL 13 BISPECIFIC ANTIBODIES
#2771METABOLICS BIOMARKER FOR NAFLD AND METHODS OF USE
#2772Markers of the male urogenital tract
#2773Health test for a broad spectrum of health problems
#2774NEW MARKERS FOR THE ASSESSMENT OF THE RISK FOR DEVELOPMENT OF A CARDIOVASCULAR DISORDER
#2775DETECTION, MONITORING AND TREATMENT OF ACUTE MYOCARDIAL INFARCTION
#2776Predicting mortality and detecting severe disease
#2777BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOF
#2778A Diagnostic Marker For Paget's Disease
#2779Methods for the prediction of a personalized ESA-dose in the treatment of anemia
#2780Circulating KIM-1 levels for detection of pathologies associated with injury to, or cancer of, the kidney
#2781METHODS AND COMPOSITIONS FOR ASSESSING PREDICTING RESPONSIVENESS TO A TNF INHIBITOR
#2782Antibodies against HPA-1a
#2783Anti-transthyretin antibodies
#2784Bacteriophage gene 3 protein compositions and use as amyloid binding agents
#2785PREDICTING RAPID DECLINE IN RENAL FUNCTION IN DIABETES
#2786Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2
#2787Diagnosis of hematologic diseases
#2788culture medium
#2789Genetically encoded histone reporter allele constructs
#2790Human liver scaffolds
#2791USE OF BIOMARKERS FOR DETECTION OF EXCESSIVE ALCOHOL USE
#2792Monitoring Inflammation Status
#2793METHOD FOR INCREASING THE SENSITIVITY OF IMMUNOASSAY SYSTEM THROUGH PRETREATMENT OF URINE WITH DENATURANT
#2794Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
#2795NEW MARKERS FOR THE ASSESSMENT OF AN INCREASED RISK FOR MORTALITY
#2796Methods for diagnosing and treating subjects for pulmonary exacerbation
#2797Method to optimize the treatment of patients with biological drugs
#2798USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#2799Early Diagnosis of Autoimmune and Inflammatory Disorders
#2800Method and kit for prognosis of OPA1 gene induced diseases, E.G. Kjers optic atrophy
#2801Chemical and biochemical adducts as biomarkers for organophosphate exposure
#2802POTENTIATOR-CORRECTOR COMBINATIONS USEFUL IN THE TREATMENT OF CYSTIC FIBROSIS
#2803Treatment of circadian rhythm disorders
#2804Buccal cell diagnosis of arrhythmogenic cardiomyopathy (ACM)
#2805Methods for diagnosing and assessing risk of developing glomerulosclerosis
#2806Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof
#2807Anti-GP73 monoclonal antibodies and methods of obtaining the same
#2808METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS
#2809Methods and apparatuses for conducting analyses
#2810METHOD OF TESTING FOR PULMONARY HYPERTENSION
#2811BCL6 expression in eutopic endometrium as a marker for endometriosis and subfertility
#2812Methods and compositions for wound treatment
#2813METHODS FOR ASSESSING RESPONSIVENESS TO ASTHMA TREATMENT BASED ON VNN-1 EXPRESSION AND PROMOTER METHYLATION
#2814Methods of predicting acute rejection outcomes
#2815Replacement Therapy for Natriuretic Peptide Deficiencies
#2816Treatment of circadian rhythm disorders
#2817PREDICTION AND RECOGNITION OF ACUTE KIDNEY INJURY AFTER SURGERY
#2818Methods and compositions for diagnosis and treatment of meningitis
#2819C1q-ADIPONECTIN COMPLEX AND USE THEREOF
#2820Method of treating BCL-2 over-expressing disorders using arts containing a BH3-like domain
#2821Method of binding a CSE1L tumor marker in a tumor of an animal
#2822Treatment or prevention of an intestinal disease or disorder
#2823TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#2824Identification of novel diagnostics and therapeutics by modulating RhoH
#2825Minimally-invasive measurement of esophageal inflammation
#2826Methods of Determining Efficacy of Therapy For Niemann-Pick C Disease And Related Disorders
#2827Methods useful for vitamin D deficiency and related disorders
#2828COMPOSITIONS AND METHODS FOR DIAGNOSING BARRETT'S ESOPHAGUS STAGES
#2829Detection of platelet-derived shed CD31
#2830Gram-positive bacteria specific binding compounds
#2831Evaluation of eosinophilic esophagitis
#2832Method of treatment of chlamydial infections with selected EGFR inhibitors
#2833In vitro detection of prions in blood
#2834In vitro diagnostic and prognosis of major adverse events in patients undergoing coronary angiography
#2835METHODS AND MATERIALS FOR CHARACTERIZING INTESTINAL BARRIER FUNCTION
#2836METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF KAWASAKI DISEASE
#2837Molecular Imaging Probes
#2838Progranulin (PGRN) and its derivatives for diagnosis and treatment of lysosomal storage diseases
#2839Pdia4 protein as a target for diagnosis, monitoring and treatment of diabetes
#2840METHOD AND MEANS FOR THE NON-INVASIVE DIAGNOSIS OF TYPE II DIABETES MELLITUS
#2841Method for treating or preventing a pancreatic dysfunction
#2842ELISA for a Naturally-Occurring Soluble Truncated Form of IL-23 Receptor
#2843Methods of comparing anti-vinculin and anti-cytolethal distending toxin antibodies as they relate to irritable bowel syndrome
#2844Methods for detection of depressive disorders
#2845Biomarkers for painful intervertebral discs and methods of use thereof
#2846DIAGNOSIS OF CHRONIC KIDNEY DISEASE BY QUANTITATIVE ANALYSIS OF POST-TRANSLATIONAL MODIFICATIONS OF PLASMA PROTEINS
#2847Protein biomarkers for immune assessment and prediction of transplant rejection
#2848METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#2849MARKER OF NEUROPATHIC GAUCHER'S DISEASE AND METHODS OF USE THEREOF
#2850Materials and methods for diagnosing and predicting the course of prostate cancer
#2851PROGNOSTIC KITS, ARRAYS COMPOSITIONS AND METHODS FOR PREDICTING INTERFERON TREATMENT EFFICACY IN A SUBJECT
#2852Biomarkers for diagnosing ischemia
#2853Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#2854CaMKK-β as a target for treating cancer
#2855Compositions and methods of inhibiting histone deacetylases
#2856Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
#2857SURROGATES OF POST-TRANSLATIONALLY MODIFIED PROTEINS AND USES THEREOF
#2858Prognosing mortality in patients with chronic kidney disease by detecting macrophage inhibitory cytokine-1 (MIC-1)
#2859Electrochemical methods and devices for amending urine samples for immunosensor detection
#2860Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#2861Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#2862METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB
#2863Peanut formulations and uses thereof
#2864Qualitative predictive method for differential diagnosis of pneumococcal meningococcal and viral meningitis, method and kit for differential diagnosis of meningitis
#2865Use of IGFBP-7 in the assessment of heart failure
#2866Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#2867Method for detecting cardiovascular disease biomarker
#2868SCREENING TARGETS AND COMPOSITIONS AND METHODS FOR TREATMENT OF CILIOPATHY DISORDERS
#2869NEPHROPATHY BIOMARKER
#2870KIT FOR MONITORING, DETECTING AND STAGING GVHD
#2871Device for detecting misfolded proteins and methods of use thereof
#2872MARKERS OF ACUTE KIDNEY FAILURE
#2873Biomarkers For Endometriosis
#2874BAG3 as a target for therapy of heart failure
#2875Anti-transthyretin antibodies
#2876FREE RAPTOR REDUCES AGING- AND OBESITY-INDUCED FATTY LIVER
#2877Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP
#2878Adrenomedullin to guide therapy of blood pressure decline
#2879IGFBP7 for diagnosing diastolic dysfunction
#2880GALECTIN-9-SECRETING CELL, AND PRODUCTION METHOD AND USE OF THE SAME
#2881Biomarker panel for assessment of mucosal healing
#2882GDF15 AS BIOMARKER FOR DIAGNOSING MITOCHONDRIAL DISEASES
#2883Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
#2884Exosome-mediated diagnosis of hepatitis virus infections and diseases
#2885Eye disease treatment agent, screening method therefor, and method for predicting rejection response associated with retinal pigment epithelial cell transplant
#2886Polymer particles and uses thereof
#2887BIOMARKER TEST FOR ACUTE CORONARY SYNDROME
#2888METHOD TO PREDICT RESPONSE TO PHARMACOLOGICAL CHAPERONE TREATMENT OF DISEASES
#2889Methods for detection of respiratory diseases
#2890DETECTING PODOCYTE INJURY IN DIABETIC NEPHROPATHY AND GLOMERULONEPHRITIS
#2891NGAL for Diagnosis of Renal Conditions
#2892Protein and lipid biomarkers providing consistent improvement to the prediction of Type 2 diabetes
#2893Methods and systems for diagnosing diseases
#2894Diagnostic and immunotherapy compositions and methods for disease states mediated by inhibitor-resistant CD8 T-cells
#2895Cystic fibrosis transmembrane conductance regulator gene mutations
#2896Inhibitors of thioredoxin-interacting protein (TXNIP) for therapy
#2897STAT3 phosphorylation during graft-versus-host disease
#2898Bcl-2-like protein 11 SRM/MRM assay
#2899METHOD FOR DIGANOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36
#2900METHOD OF DIAGNOSING RENAL DISORDERS
#2901Biomarkers for determining an allograft tolerant phenotype
#2902Human islet amyloid polypeptide (HIAPP) specific antibodies and uses thereof
#2903Compositions and methods to treat inflammatory joint disease
#2904Herbal Combinations for Treating Eczema
#2905PROTEIN ACTIVITY MODIFICATION
#2906NEUROFIBROMIN/DOPAMINE SIGNALING AS A BIOMARKER FOR COGNITIVE AND BEHAVIORAL PROBLEMS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1)
#2907Radical species, and method for measuring received doses
#2908SUSCEPTIBILITY TO BONE DAMAGE
#2909METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIA
#2910Methods for treating disorders that involve immunoglobulin A
#2911Biomarkers of mineralocorticoid receptor activation
#2912Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#2913Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity
#2914TREATMENT OF CARDIAC DISEASES WITH MODULATORS OF THE HIPPO PATHWAY
#2915NOVEL SET OF FASTING BLOOD BIOMARKERS TO DETECT PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE
#2916Methods for Early Diagnosis of Kidney Disease
#2917HUMAN BIOMARKER TEST FOR MAJOR DEPRESSIVE DISORDER
#2918LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES
#2919SIGNALING PATHWAYS IN TISSUES FROM INFLAMMATORY BOWEL DISEASE PATIENTS
#2920Expression of ETS related gene (ERG) and phosphatase and tensin homolog (PTEN) correlates with prostate cancer capsular penetration
#2921THERAPEUTIC AND DIAGNOSTIC MOLECULES
#2922Humanized anti-complement factor C1Q antibodies
#2923Diagnosis of a neuroautoimmune disease comprising measuring autoantibodies to flotillin1 and/or flotillin2
#2924Method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes
#2925Replacement Therapy for Natriuretic Peptide Deficiencies
#2926METHODS OF DIAGNOSING AND TREATING ASTHMA
#2927BIOMARKERS FOR CARDIOVASCULAR DISEASE
#2928METHOD FOR DETERMINATION OF THE STATUS OF A DISEASE
#2929Human blood molecular biodosimeter panel for distinguishing radiation exposure from inflammation stress
#2930BIOMARKER FOR HUMAN EYES AND METHOD THEREOF
#2931Pharmaceutical compositions containing peptides derived from human BPLP protein
#2932Methods for the prevention and the treatment of extracapillary glomerulonephritis
#2933Anti-mesothelin binding proteins
#2934Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#2935METHODS AND MONITORING OF TREATMENT WITH A DLL4 ANTAGONIST
#2936Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#2937Method and means for diagnosing and treating allergy
#2938Biochemical markers for pulmonary and other diseases
#2939Therapeutic and diagnostic methods for autism spectrum disorders and other conditions
#2940Microparticle fractionation
#2941AGENTS, METHODS AND KITS FOR TREATING AND DETECTING DIABETIC NEPHROPATHY AND PROLIFERATIVE DISEASES AND METHODS FOR INHIBITING EXPRESSION OF TYPE IV COLLAGEN
#2942Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy
#2943Lectin Assay For Assessing Glycoforms As An Early Marker In Disease
#2944Diagnosis of chronic liver diseases
#2945Biomarker and uses thereof
#2946Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA
#2947Method for diagnosing lung diseases
#2948Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
#2949COMPOSITIONS AND METHODS FOR IDENTIFYING, MODULATING AND MONITORING DRUG TARGETS IN MUSCULAR DISEASE
#2950Compositions and methods for diagnosis and treatment of metabolic syndrome
#2951Prognosis of adverse events in patients with suspected chronic heart failure
#2952Biomarkers and methods for progression prediction for chronic kidney disease
#2953Compositions for diagnosing episodic movement disorders and related conditions
#2954COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS, CONTAINING PROGRANULIN INHIBITOR AS ACTIVE INGREDIENT
#2955DRG11-RESPONSIVE (DRAGON) GENE AND USES THEREOF
#2956Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof
#2957Method of preventing or treating skin necroptosis disease comprising RIP3-MLKL pathway blocker
#2958Diagnosis of liver pathology through assessment of protein glycosylation
#2959ANTIBODY CAPABLE OF BINDING TO SPECIFIC REGION OF PERIOSTIN, AND METHOD FOR MEASURING PERIOSTIN USING SAME
#2960METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE USING TREFOIL FACTOR 3 FAILURE
#2961METHOD OF DIAGNOSIS AND TREATMENT
#2962BACTERIAL INFLUENCE ON REGULATION OF APPETITE VIA CLPB PROTEIN MIMICRY OF ALPHA-MSH
#2963Methods to Diagnose Treat and Prevent Bone Loss
#2964Method for discriminating between prostate cancer and a benign prostate disease
#2965Methods of determining eosinophilic gastritis status based on marker or gene expression
#2966LPS serotypes for determining severity of urinary tract infection
#2967TETRASPANIN CD82 AS A DIAGNOSTIC AND/OR THERAPEUTIC MODULE FOR XENOGRAFT RECOGNITION AND/OR REJECTION
#2968Methods for discriminating between prostate cancer and a benign prostate-disease
#2969DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK
#2970BIOMARKER FOR HUMAN EYES AND METHOD THEREOF
#2971Biomarkers for detecting pre-cachexia or cachexia and methods of treatment thereof
#2972Multi-metabolites platform for diagnosis of acute coronary syndrome
#2973Compositions and methods for treatment of muscular dystrophy
#2974Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#2975DIABETES PANEL
#2976Methods for diagnosing osteoarthritis
#2977Biomarker for cardiac disorders
#2978Methods of treating or selecting a treatment for a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#2979Method for detecting nucleosomes containing histone variants
#2980COMPOSITIONS AND METHODS OF TREATING THROMBOSIS
#2981Pharmaceutical compositions comprising DENND1A variant 2 and methods of use thereof
#2982Methods for treating cancer using combination therapies
#2983Methods and Compositions for the Treatment of Proteinuric Diseases
#2984Compositions and methods for treating vitiligo
#2985Methods for determining differences in alpha-4 integrin activity by correlating differences in sVCAM and/or sMAdCAM levels
#2986Composition comprising a cell sample from a subject with scoliosis and a reagent for detecting PTPμ or PIPK1y
#2987Devices and assays for diagnosis of sinusitis
#2988Biomarkers for the diagnosis of lacunar stroke
#2989Siglec-15 antibodies in treating bone loss-related disease
#2990Assays for IGFBP7 having improved performance in biological samples
#2991COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES INVOLVING HIPPO PATHWAY
#2992MELANOMA CHEMOPREVENTION
#2993ASSAY FOR INSULIN-DEGRADING ENZYME (IDE) INHIBITORS
#2994Biochemical markers for CVD risk assessment
#2995Method for diagnosing and monitoring inflammatory disease progression
#2996METHOD AND APPARATUS FOR DETECTING VECTOR-BORNE DISEASES IN MAMMALS
#2997Compositions and methods for diagnosing and treating an inflammation
#2998Epitopes related to coeliac disease
#2999Methods of treating metabolic disorders
#3000MODULATION OF EPIGENETIC STRESS RESPONSE